Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the efficacy and safety of Beta-1,3/1,6-D-Glucan from
mycelium extract of Ganoderma lucidum on ulcerative colitis